7th April 2017

As reported by George Psyllides, in Cyprus Mail online, the health ministry of Cyprus should roll out measures as soon as possible to tackle the absence of competition and monopolistic conditions in the pharmaceutical market which drive up prices, in some cases, hurting public interest, the auditor-general said in a special report on the issue.

Read the full article here